Published Date: 31-May-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Molecular Quality Controls Market size is expected to reach $259.4 million by 2028, rising at a Market growth of 6.6% CAGR during the forecast period.
The Single-analyte Controls segment is leading the Global Molecular Quality Controls Market by Analyte Type 2021; thereby, achieving a Market value of $179.3 million by 2028. It is due to the widespread use of singleplex assays in hospitals and the benefits associated with single-analyte controls, such as straightforward interpretation and analysis and little risk of cross-reactivity.
The Oncology Testing Market has shown growth rate of 6.9% during (2022 - 2028). It is due to the sheer rising incidences of cancer, more research on cancer biomarkers, enhanced diagnosis infrastructure, and a growing focus on tailored medicine, the oncology segment generates the most Market revenue.
The Independent Controls segment acquired maximum revenue share in the Global Molecular Quality Controls Market by Product 2021; thereby, achieving a Market value of $152.1 million by 2028. The growth of the molecular quality control products Market is being driven by an increase in the number of accredited laboratories and governmental regulations for the adoption of quality controls to validate the consistency of diagnostic test findings.
The Academic & Research Institutes segment is showcasing a CAGR of 7.9% during (2022 - 2028). This is due to large-scale research efforts happening across academic and research institutes. In 2018, for example, Thermo Fisher Scientific teamed up with Sichuan University in China to develop training facilities for standardized pathology quality control, standardized pathological diagnosticians, and advanced laboratories.
North America region is the fastest growing region in the Global Molecular Quality Controls Market by Region 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $101.7 million by 2028. The Europe Market is estimated to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The Asia Pacific Market would exhibit a CAGR of 6.7% during (2022 - 2028).
The Market research report has exhaustive quantitative insights providing a clear picture of the Market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the Market have been discussed in the report with the elaborated company profiles of Grifols, S.A, Abbott Laboratories, Quidel Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Seegene, Inc., Randox Laboratories Limited, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, and Microbiologics, Inc.
By Analyte Type
By End User
Unique Offerings from KBV Research